平安生物医药宣布,公司已正式签订证券购买协议,计划通过非公开发行方式发行并出售1亿股普通股。此次私募配售旨在进一步优化公司资本结构,为未来业务拓展和研发投入提供资金支持。
平安生物医药宣布,公司已正式签订证券购买协议,计划通过非公开发行方式发行并出售1亿股普通股。此次私募配售旨在进一步优化公司资本结构,为未来业务拓展和研发投入提供资金支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.